← Leaderboards
Christopher A Loffredo
Georgetown University
$8,219,689
Attributed
$8,219,689
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,219,689 · 8
By mechanism
R01$7,881,352 · 4
P30$246,495 · 1
P20$83,752 · 2
M01$8,090 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Egypt”
- Clarence J. Peters · University Of Texas Medical Br Galveston$8,206,893
- Deborah A. Fein · University Of Connecticut Storrs$5,443,119
- Radoslav Goldman · Georgetown University$3,771,858
- Jon Mark Hirshon · University Of Maryland Baltimore$3,529,672
- Arland D Thornton · University Of Michigan At Ann Arbor$3,193,809
- Diane S Rohlman · Oregon Health & Science University$3,189,367
Research focus
EgyptRisk FactorsGene Environment InteractionMalignant NeoplasmsCancer RiskAreaResearch PersonnelEtiologyCancer ControlRecruitment ActivityProgramsResponseBaseGenesResourcesHepatitis C VirusPrevalenceCase-Control StudiesExposure ToFemaleEpidemiologyEnvironmental Risk FactorCountryGenetic Predisposition To Disease
Grant awards (27)
Research Program - Cancer Prevention & Control$82,165
P30 · FY2021 · CA · contact PI
Research Program - Cancer Prevention & Control$82,165
P30 · FY2020 · CA · contact PI
Research Program - Cancer Prevention & Control$82,165
P30 · FY2019 · CA · contact PI
Fatty Liver Disease in African Americans$66,674
P20 · FY2019 · CA · contact PI
Cancer Research Education Program$17,078
P20 · FY2019 · CA · contact PI
Prevalence and Correlates of Youth Drug Abuse in Egypt$379,107
R01 · FY2013 · DA · contact PI
Prevalence and Correlates of Youth Drug Abuse in Egypt$398,458
R01 · FY2012 · DA · contact PI
Prevalence and Correlates of Youth Drug Abuse in Egypt$405,534
R01 · FY2011 · DA · contact PI
Gender Differences in Bladder Cancer Risk Factors$442,548
R01 · FY2010 · CA · contact PI
Prevalence and Correlates of Youth Drug Abuse in Egypt$441,208
R01 · FY2010 · DA · contact PI
Gender Differences in Bladder Cancer Risk Factors$438,045
R01 · FY2009 · CA · contact PI
Malignant Complications of Chronic HCV$295,888
R01 · FY2009 · CA · contact PI
Gender Differences in Bladder Cancer Risk Factors$425,728
R01 · FY2008 · CA · contact PI
Malignant Complications of Chronic HCV$297,351
R01 · FY2008 · CA · contact PI
Gender Differences in Bladder Cancer Risk Factors$421,975
R01 · FY2007 · CA · contact PI
Malignant Complications of Chronic HCV$307,846
R01 · FY2007 · CA · contact PI
Egypt Smoking Prevention Research Initiative$495,084
R01 · FY2006 · TW · contact PI
Gender Differences in Bladder Cancer Risk Factors$456,479
R01 · FY2006 · CA · contact PI
Malignant Complications of Chronic HCV$307,979
R01 · FY2006 · CA · contact PI
Egypt Smoking Prevention Research Initiative$521,529
R01 · FY2005 · TW
Malignant Complications of Chronic HCV$342,712
R01 · FY2005 · CA
EPIDEMIOLOGICAL STUDY OF CONGENITAL HEART MALFORMATIONS$8,090
M01 · FY2005 · RR
MALIGNANT COMPLICATIONS OF CHRONIC HCV$346,317
R01 · FY2003 · CA
MALIGNANT COMPLICATIONS OF CHRONIC HCV$398,862
R01 · FY2002 · CA
MALIGNANT COMPLICATIONS OF CHRONIC HCV$389,605
R01 · FY2001 · CA
MALIGNANT COMPLICATIONS OF CHRONIC HEPATITIS C VIRUS$50,619
R01 · FY2001 · CA
MALIGNANT COMPLICATIONS OF CHRONIC HEPATITIS C VIRUS$318,478
R01 · FY2000 · CA